Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 


J Res Educ Indian Med . 2014; 20(2): 67-73


CLINICAL EVALUATION OF VANGA BHASMA IN THE MANAGEMENT OF MADHUMEHA (TYPE-2 DIABETES MELLITUS)

B. J. PATGIRI, DARSHAN K. PARMAR, P. K. PRAJAPATI.




Abstract

Introduction: Madhumeha is a Vataja type of Tridoshaja disease. Vanga is used
abundantly in practice of Ayurveda for the treatment of Madhumeha. It is a drug of choice for the
management of Madhumeha (DM-II). Guduchi Ghana ( aqueous extract of Tinospora cordifolia
(Willd.) Miers) of is also having Mehahara effect and old honey is also to be claimed for Mehaghna
properties. Material and methods: In present study total 64 patients were registered. Out of them
in Group A total 32 patients were managed with Vanga Bhasma (250 mg) along with Guduchi
Ghana (250 mg) + Old Honey (3 ml) as Sahapana whereas in Group B, 32 patients were managed
with Guduchi Ghana (250 mg) + Old Honey (3 ml) for 28 days. Observations and Results: Present
study 14%, 28% and 10% of patients markedly improvement, moderate improvement, mildly
improvement were found in Group A respectively. While 2%, 10% and 24% markedly improvement,
moderate improvement, and mildly improvement were found in Group B respectively. Overall
result showed that Vanga Bhasma possesses the antihyperglycemic effect along with its Sahapana
and it doesn’t have hypoglycemic effect. Conclusion: Vanga Bhasma with Sahapana (Guduchi
Ghana) was found moderate anti-hyperglycemic agent in the patients of Madhumeha (Type-2
Diabetes Mellitus)).

Key words: yurvedic treatment; Diabetes mellitus; Guduchi Ghana; Madhumeha; Madhu; Honey; Vanga Bhasma.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.